ZBIO
Zenas Biopharma Inc.

416
Mkt Cap
$1.99B
Volume
328,002.00
52W High
$37.89
52W Low
$5.83
PE Ratio
-8.20
ZBIO Fundamentals
Price
$34.84
Prev Close
$37.15
Open
$37.98
50D MA
$26.24
Beta
1.70
Avg. Volume
582,663.26
EPS (Annual)
-$3.76
P/B
7.98
Rev/Employee
$38,461.54
Loading...
Loading...
News
all
press releases
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Zenas BioPharma, Inc. (NASDAQ: ZBIO)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Zenas BioPharma, Inc. (NASDAQ: ZBIO) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation...
PR Newswire·7h ago
News Placeholder
More News
News Placeholder
HC Wainwright Raises Earnings Estimates for Zenas BioPharma
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Free Report) - Equities research analysts at HC Wainwright boosted their FY2025 earnings per share estimates for shares of Zenas BioPharma in a report released on...
MarketBeat·4d ago
News Placeholder
FY2025 EPS Estimate for Zenas BioPharma Increased by Analyst
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Free Report) - Wedbush raised their FY2025 earnings per share estimates for Zenas BioPharma in a research note issued on Wednesday, November 12th. Wedbush analyst...
MarketBeat·4d ago
News Placeholder
Morgan Stanley Increases Zenas BioPharma (NASDAQ:ZBIO) Price Target to $37.00
Morgan Stanley increased their price target on shares of Zenas BioPharma from $34.00 to $37.00 and gave the company an "overweight" rating in a research report on Thursday...
MarketBeat·6d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Issues Earnings Results
Zenas BioPharma (NASDAQ:ZBIO - Get Free Report) released its earnings results on Tuesday. The company reported ($1.22) EPS for the quarter, missing analysts' consensus estimates of ($0.85) by ($0.37...
MarketBeat·7d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Trading 8.7% Higher - Should You Buy?
Zenas BioPharma (NASDAQ:ZBIO) Stock Price Up 8.7% - Time to Buy...
MarketBeat·8d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Reaches New 52-Week High - Time to Buy?
Zenas BioPharma (NASDAQ:ZBIO) Sets New 52-Week High - Here's Why...
MarketBeat·9d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Reaches New 12-Month High - Time to Buy?
Zenas BioPharma (NASDAQ:ZBIO) Hits New 12-Month High - What's Next...
MarketBeat·9d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Rating Increased to Hold at Wall Street Zen
Wall Street Zen raised Zenas BioPharma from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·11d ago

Latest ZBIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.